ZLAB vs HCM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HCM Captures Institutional Edge (2โ2 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to HUTCHMED (China) Limited American Depositary Shares (HCM) driven by superior Valuation, Growth & Margin while ZLAB counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, ZLAB trades at N/M Forward P/E with -63.0% operating margin (-6.8% YoY revenue) versus HCM at N/M Forward P/E and -6.3% operating margin (+0.2% YoY). In options structure, ZLAB sits in UNCLASSIFIED (58th %ile IV; Dealer Gamma Walls on Pro) against HCM sits in UNCLASSIFIED (73rd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ZLAB | HCM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.0B | $2.6B | Larger Scale | ZLAB |
| Trailing P/E Ratio Valuation | N/M | 148.3x | Lower Multiple | HCM |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -6.8% | +0.2% | Higher Growth | HCM |
| Operating Margin (TTM) Profitability | -63.0% | -6.3% | Higher Margin | HCM |
| Net Profit Margin Profitability | -44.9% | 3.3% | Higher Margin | HCM |
| Return on Equity (ROE) Capital Efficiency | -30.0% | 1.5% | Higher ROE | HCM |
| 52-Week Range Position Momentum | 60% ($16โ$29) | 75% ($10โ$16) | Stronger Trend | HCM |
| Beta / 30D Volatility Risk Regime | 1.19ฮฒ ยท 78% Vol | 0.61ฮฒ ยท 45% Vol | Lower Realized Risk | HCM |
| Unified Institutional Score Composite Signal | 47.4 / 100 (HOLD) | 37.9 / 100 (SELL) | Higher Composite | ZLAB |